RxDoctor Payments Data

Jorge Reguero Hernandez, MD

Colon & Rectal Surgery · Saginaw, MINPI 1700029394

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $853 of the $1,402 with a category attached, or 60.9%. Intuitive Surgical accounts for 83.8% of it on its own, with 6 other manufacturers making up the rest. 2024 is the largest year on record at $1,174, 9.8 times the $120 reported in 2019. That places this record below the midpoint for colon & rectal surgery clinicians in MI, where the typical reported total is $2,435.

$1,402in general payments, 2019–2025

Across 16 payments — averaging $87.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • Olympus America Inc.$98
  • Takeda Pharmaceuticals U.S.A., Inc.$34
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$31
  • Braintree Laboratories, Inc.$22
  • Medtronic$22
  • plus $21 from 1 others

What the payments were for

  • Travel & lodging$54039%
  • Food & beverage$85361%
  • Gifts$91%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,402 in reported general payments places this provider in the 40th percentile of 72 colon & rectal surgery providers in Michigan.

See all colon & rectal surgery providers in Michigan

Medicare billing

Part B allowed, 2024
$79,117
Medicare patients
189
Services billed
316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SutabSod Sulf/Pot Chloride/Mag Sulf54$8,571
Neomycin Sulfate50$291
LoperamideLoperamide Hcl11$218
Tramadol Hcl85$101
Metronidazole57$84

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Braintree Laboratories, Inc.Sutab$22$8,57154 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 72 colon & rectal surgery providers in Michigan.

Other colon & rectal surgery in Saginaw

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →